Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 August;53(4) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 August;53(4):374-81

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

REVIEWS  LATEST ADVANCES IN RADIOPHARMACOLOGY AND RADIOPHARMACY 2009 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 August;53(4):374-81

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: English

The use of imaging in preclinical drug development

Vanderheyden J. L.

GE Healthcare, Healthcare Systems, Molecular Imaging, Waukesha, WI, USA


PDF


Molecular imaging tools, both equipment and agents, continue to improve and evolve, offering multimodality imaging with greater sensitivity and high-resolution of biological processes in real time. This review summarizes some of these recent developments in preclinical hardware, wetware and software, and their impact on drug development. The focus is on the advances in non-invasive small animal imaging such as positron emission tomography (PET), computed tomography (CT) and solid state detectors in single photon emission tomography (SPECT), which, when combined with labeled tracers serving as biomarkers and functional probes in vivo, are demonstrating the potential to accelerate our understanding of disease and help select drug candidates for development.

top of page